Plasminogen activator inhibitor (PAI)-1 is an inhibitor of fibrinolysis, the physiological process involved in blood clot degradation. Systemic release of PAI-1 has been associated with ischemic cardiovascular disease and poor prognosis of acute lung injury. We evaluated the induction of PAI-1 in the lung and systemic circulation of C57BL/6J mice exposed to high dose (40 ug) purified single walled carbon nanotubes (SWCNT, CNI, Inc.) or multi walled CNT (MWCNT, provided by Prof. Endo, Shinshu University, Japan) by pharyngeal aspiration. CNTs were dispersed by sonication in a dispersion solution (DS) containing mouse serum albumin and DSPC. Mice were sacrificed 4hr post-exposure and lung tissue, bronchoalveolar lavage (BAL), and blood were collected for biochemical and gene expression assessment. CNT exposure caused increased PAI-1 (approximately 5-fold) gene expression in the lung while no increase was found in the whole blood. PAI-1 protein levels were significantly increased in the lungs of both CNT-treated groups (3.57+/-0.42 ng/ml DS; 7.45+/-0.68* SWCNT; 8.16+/-0.89* MWCNT, *p<0.05). A similar trend was demonstrated for the plasma PAI-1 protein levels (1.95+/-0.19 ng/ml DS; 2.36+/-0.57 SWCNT; 2.84+/-0.38 MWCNT) as well as plasma PAI-1 activity (0.33+/-0.10 DS; 0.64+/-0.16 SWCNT; 0.80+/-0.16* MWCNT, *p<0.05). The PAI-1 activation was accompanied by induction of lung inflammation including increased influx of neutrophils in the BAL, increased BAL LDH and albumin and elevated lung tissue gene expression of numerous inflammatory genes such as (IL- 1â, MIP-2, MCP-1, and IL-6). Furthermore, acute CNT exposure induced MIP-2 and IL-1â gene expression in the blood cells from the systemic circulation. All these effects were more prominent and consistent in mice exposed to MWCNT compared to the mice exposed to SWCNT. In conclusion, CNT-induced acute lung inflammation was associated with a systemic response which may lead to disturbances in the coagulation cascade and vascular endothelial function.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.